A Study to Test How Well Men Tolerate Different Doses of BI 3006337

NCT05076422 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

80

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 3006337
DRUG: Placebo

Sponsor

Boehringer Ingelheim